Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

NAMSW

NewAmsterdam Pharma Company N.V.

USD

Set alert

Price alert · NAMSW

All alert types
8.98 USD -1.77 -16.42%
As of Oct 30, 2026 Extended hours 23.50 +161.56%
Bid
8.50 × —
Ask
9.78 × —
8.68 Day range 9.23
8.25 52-week range 29.99
YTD
-60.94%
1 year
-67.09%
Open
24.41
Prev close
10.75
Mkt cap
2.25B
Vol
2.41K
Avg vol
1.20K
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
8.68
High
9.23
Forward P/E
0.00
Beta
0.10
Short ratio
0.00
Inst. own
0.00%
Dividend
0.00
Ex-div date
Earnings
Nov 11, 2026
50-d avg
12.22
200-d avg
19.03
1y target
0.00

5D chart

Chart tools
Interval
1m5m15m30m
NAMSW five-day price chart8.688.828.969.099.239:30 AM9:35 AM11:45 AM

Financial health

Altman Z-Score

25.59 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 5
  • P/E 1
  • P/B 1

Valuation

P/E -20.0×
FY 2020: 4614×FY 2021: -2.9×FY 2022: -9.2×FY 2023: -5.2×FY 2024: -10.0×FY 2025: -20.0×
FY 2020 5y median -9.2× FY 2025
P/S 178×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: 2.0×FY 2023: 65.1×FY 2024: 53.2×FY 2025: 178×
FY 2020 5y median 53.2× FY 2025
P/B 5.9×
FY 2020: 1.5×FY 2021: 3.1×FY 2022: 0.5×FY 2023: 3.2×FY 2024: 3.2×FY 2025: 5.9×
FY 2020 5y median 3.2× FY 2025
P/FCF -27.1×
FY 2020: -25.6×FY 2021: -5.9×FY 2022: 19.8×FY 2023: -6.5×FY 2024: -15.2×FY 2025: -27.1×
FY 2020 5y median -6.5× FY 2025
EV/EBITDA -14.5×
FY 2020: -28.2×FY 2021: -2.7×FY 2022: 11.7×FY 2023: -3.3×FY 2024: -6.8×FY 2025: -14.5×
FY 2020 5y median -3.3× FY 2025
EV/Sales 157×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: -2.5×FY 2023: 41.0×FY 2024: 36.3×FY 2025: 157×
FY 2020 5y median 36.3× FY 2025
FCF Yield -3.7%
FY 2020: -3.9%FY 2021: -17.1%FY 2022: 5.1%FY 2023: -15.4%FY 2024: -6.6%FY 2025: -3.7%
FY 2020 5y median -6.6% FY 2025

Profitability

Gross Margin 99.7%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 99.7%
FY 2020 5y median 100.0% FY 2025
Operating Margin -1002.9%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: -3.5%FY 2023: -1298.6%FY 2024: -386.9%FY 2025: -1002.9%
FY 2020 5y median -386.9% FY 2025
Net Margin -905.7%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: -22.0%FY 2023: -1255.8%FY 2024: -530.3%FY 2025: -905.7%
FY 2020 5y median -530.3% FY 2025
ROE -29.8%
FY 2020: -5.5%FY 2021: -73.8%FY 2022: -5.3%FY 2023: -61.4%FY 2024: -31.9%FY 2025: -29.8%
FY 2020 5y median -31.9% FY 2025
ROIC -33.0%
FY 2020: -4.7%FY 2021: -61.6%FY 2022: -0.8%FY 2023: -61.6%FY 2024: -23.3%FY 2025: -33.0%
FY 2020 5y median -33.0% FY 2025
ROA -26.5%
FY 2020: -5.0%FY 2021: -61.5%FY 2022: -4.7%FY 2023: -51.0%FY 2024: -27.9%FY 2025: -26.5%
FY 2020 5y median -27.9% FY 2025

Growth (YoY)

Revenue -50.6%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -86.3%FY 2024: 223.4%FY 2025: -50.6%
FY 2020 FY 2025
Operating Income -28.0%
FY 2020: 0.0%FY 2021: -427.4%FY 2022: 89.8%FY 2023: -5043.9%FY 2024: 3.6%FY 2025: -28.0%
FY 2020 FY 2025
EPS (diluted) 31.6%
FY 2020: 0.0%FY 2021: -145317.4%FY 2022: 64.4%FY 2023: -80.7%FY 2024: -19.1%FY 2025: 31.6%
FY 2020 FY 2025
Free Cash Flow 7.0%
FY 2020: 0.0%FY 2021: -301.4%FY 2022: 135.4%FY 2023: -1452.4%FY 2024: -12.7%FY 2025: 7.0%
FY 2020 FY 2025

Financial Health

Current Ratio 7.9×
FY 2020: 7.9×FY 2021: 6.0×FY 2022: 13.3×FY 2023: 7.0×FY 2024: 8.1×FY 2025: 7.9×
FY 2020 5y median 7.9× FY 2025
Quick Ratio 7.9×
FY 2020: 7.9×FY 2021: 6.0×FY 2022: 13.3×FY 2023: 7.0×FY 2024: 8.1×FY 2025: 7.9×
FY 2020 5y median 7.9× FY 2025
Debt / Equity 0.0×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2020 5y median 0.0× FY 2025
Net Debt / EBITDA 2.0×
FY 2020: 0.2×FY 2021: 1.5×FY 2022: 20.9×FY 2023: 1.9×FY 2024: 3.2×FY 2025: 2.0×
FY 2020 5y median 2.0× FY 2025
Interest Coverage 0.0×
FY 2020: 0.0×FY 2021: -85.1×FY 2022: -12.4×FY 2023: -26.9×FY 2024: 0.0×FY 2025: 0.0×
FY 2020 5y median -12.4× FY 2025

Dividends

Dividend Yield 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31